HSTO News and Press, Histogen Inc. From 07/12/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Bed Bath & Beyond (NASDAQ: BBBY ) stock is in the news today after an incredibly bearish analyst said the retailer’s shares will fall to $1 a piece . Loop Capital analyst Antho...

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases, announced tod...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: John Brueske / Shutterstock.com Histogen (NASDAQ: HSTO ) stock is rocketing higher on Tuesday despite a lack of news concerning the clinical-stage therapeutics company. Instead, it looks like we have h...

Gainers: Greenwich LifeSciences ( GLSI ) +41% . Histogen ( HSTO ) +37% . Oramed Pharmaceuticals ( ORMP ) +25% . InMode ( INMD ) +13% . Annexon ( ANNX ) +11% . Losers: Can-Fite BioPharma ( CANF ) -11% . Arc...

Histogen ( HSTO ) +78% . Canoo ( GOEV ) +74% after signing a deal with Walmart for 4,500 all electric delivery vehicles. Novo Integrated Sciences ( NVOS ) +14% expects to report over fivefold increase in Q3 revenue. Annexon ( ANNX ) +13% p...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com Investors seeking news of the biggest pre-market stock movers for Tuesday are in the right place as we cover the gainer and losers traders need to know about this morning. We&#...

SAN DIEGO, March 30, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today a...

SAN DIEGO, March 25, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function has appo...

Innovation, R&D and an aging population are long-term secular trends that will provide a tailwind to the biotechnology sector. The Insurgent AI Deep Innovation Model uses Deep Learning and secular tailwinds to generate alpha. Evaluating investment strategies is challenging, es...

SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO) and Amerimmune LLC today announced dosing the first patient in a Phase 1 study of emricasan in mild symptomatic -COVID-19 patients to assess safety, tolerability, and preliminary efficacy. SUNY Downstate Medical Cent...